Apple Beat the Quarter and Got Sold Anyway

Yesterday this brief ended on a line: tonight, Apple gets graded. Well, the grade came in — and it tells you everything about the market we're in right now. Apple beat the quarter cleanly and got sold anyway, because the one line underneath the beat — what the holiday quarter's margins will look like — pointed the wrong way. That is the thread running through the whole tape this morning: in this market, good numbers are just the cover charge. What gets traded is the bill that comes after them.

The beat that still fell

Start with Apple itself. Fiscal fourth-quarter revenue came in at $114.5 billion, up 12%, ahead of the $113.39 billion analysts expected. Earnings were $2.10 a share against $1.99 expected, iPhone revenue rose 17% to $57.6 billion, and Services set an all-time record at $31.6 billion. A record September quarter, capping the best fiscal year in the company's history. And the stock fell — down in after-hours trading Monday, and down about 4.5% in premarket trading this morning. Why? Because Apple guided December-quarter gross margin to 45% to 46%, below the 46.3% Wall Street had penciled in, and pointed straight at rising memory-chip costs. The quarter was great. The next quarter's costs are the story. In a market still grading the AI buildout, a margin warning from the biggest name in tech lands like a spending warning from everyone.

Palantir told the same story in a different accent, also Monday after the close. Third-quarter revenue of $2.31 billion, up 96% year over year, beat the $2.18 billion expected. Adjusted earnings of $0.44 beat the $0.41 expected. U.S. commercial revenue jumped 148% and passed U.S. government revenue for the first time in the company's history — and management raised the full-year revenue guide to about $8.53 billion. The stock still slipped after hours, because U.S. commercial contract value — the bookings line that predicts tomorrow's revenue — grew only 11%, after growing 153% in the second quarter. Beat the present, wobble on the future, get sold. Same grade, same handwriting.

One trade unwinding, one collecting

And the tape underneath them split in two. The Dow rose 0.41% to 51,983.98 — the only major index in the green — carried by consumer discretionary, materials, and financials. The S&P 500 fell 0.51% to 7,541.40, its third straight loss. The Nasdaq Composite fell 1.07% to 25,164.32, and the Nasdaq-100 fell 1.39% — which, as Reuters noted, puts it more than 10% below its record close. That is the textbook definition of a correction, and it is now official: the index that carried the AI trade is in one. Technology as a sector fell 2.66%, its third straight down day, and the chip index dropped 3.37%. Intel fell another 8.8%. Marvell fell 12.72%. This was not a market falling. This was one trade being unwound while the old economy collected the money.

The purest version of that trade printed its own headline Monday. Oracle said it will raise $20 billion — roughly $10 billion in new stock, priced later Monday at $116 a share, an 11.2% discount, and $10 billion in bonds carrying coupons of 7% to 8.65%, maturing between 2029 and 2046 — to fund its AI and cloud buildout. Here's the part that stung: just five days earlier, at its investor day, Oracle had told the market that $20 billion was the ceiling on additional raises all the way through fiscal 2030. On Monday it used the entire four-year allowance in a single morning. The stock fell 8.8% to $119.22, down about 39% for the year, on a balance sheet that already carried $125.34 billion of borrowings against $67.36 billion of fiscal 2026 revenue. The market's question from last week has not changed. It has just started charging more for the answer.

Oil's round trip, crypto's slide

Oil did a full round trip while all this was happening. On Monday, hopes that U.S.–Iran talks could end the war knocked more than 7% off crude in a day — WTI settled down 7.36% at $96.46, Brent down 7.63% at $104.77, the biggest one-day drop in months. Energy stocks fell almost 4% with it. Then Tuesday morning, the story reversed: U.S. forces struck Iran's Qeshm Island in the Strait of Hormuz, an Iranian official said a deal to end the war was far off, and by 07:44 GMT WTI was back up 1.66% at $98.06, with Brent up 1.76% at $106.61. One headline took 7% out of oil. The next headline put some of it back. Nothing about supply changed in between — only the odds of a peace that would change it, priced and repriced inside 24 hours.

Crypto moved with the tech trade, because right now crypto is the tech trade with longer hours. Bitcoin changed hands around $76,000 to $77,000, down about 2% over 24 hours, testing the $76,000 support zone that has held since August. Ethereum sat around $2,250, down about 1.5% to 2%. The total crypto market fell about 2% to roughly $2.57 trillion, a six-week low, and the Fear & Greed Index dropped to 26 — Fear, one point above Extreme Fear, down from 37 yesterday and 65 a month ago. A three-month low in sentiment, in other words, with the Binance cleanup still running in the background: this morning, Binance opened the second phase of withdrawal reopening — more networks and assets coming back online progressively from 04:00 UTC — and the outflow picture has calmed, with DefiLlama data putting Monday's net outflows at $2.57 billion, down from $6.1 billion on Sunday. The next proof point is tomorrow, November 4, when Binance publishes a fresh reserve snapshot covering more coins. The exchange says about 95% of the stolen funds have been replaced from its own resources. Tomorrow's snapshot is where that claim gets its next check.

Election Day, priced

And hanging over all of it today: Americans are voting in the midterm elections. Polls favor Democrats to take the House, with the Senate too close to call, and prediction markets are pricing it more aggressively — prices aggregated by BetInt on Monday implied a 95% chance Democrats take the House and 76% for the Senate. More than $1.48 billion has been wagered on these midterms, with Kalshi alone reporting $1.33 billion of trading volume — the biggest test these markets have ever faced. Why a market brief cares: a Democratic sweep is being read on Wall Street as tougher oversight of AI and more corporate regulation, landing right on top of the trade that's already wobbling. For what it's worth, options on the S&P 500 are priced for only about a 0.8% move on Wednesday — the market expects the election to remove an overhang, not drop a new one.

The earnings desk

Two more prints landed this morning before the open, and they split exactly along the day's thread. Pfizer cleared the bar with room to spare: adjusted earnings of $0.87 a share against $0.73 expected, revenue of $16.6 billion against about $15.87 billion expected, powered by Eliquis and its newer cancer drugs — and management raised the full-year guide, to $62–64 billion of revenue and $2.95 to $3.05 of adjusted earnings. The stock ticked up in premarket trading. Pfizer promised more and guided up, so it got paid. Shopify did the opposite. Adjusted earnings of $0.49 beat the $0.47 expected, and revenue grew 32% to $3.74 billion — but gross merchandise volume, the total value of everything sold through its merchants, came in at $119.1 billion against about $121 billion expected, and growth slowed from the second quarter. The stock sank roughly 19% in premarket trading, on pace for its worst day on record if it holds. Beat the earnings line, miss the volume line, get punished like you missed everything. That's the consumer warning inside the print, too: the engine under Shopify's numbers — people actually buying things — grew a touch slower than the market demanded.

Tonight after the close, the grading continues. AMD is the big one — consensus around $1.97 a share on about $13.22 billion of revenue, with options pricing a move of about 9% either way; it will be judged on AI graphics-chip demand and whether the guide justifies a stock that fell seven-plus percent on Monday ahead of the print. Super Micro Computer reports too — about $1.26 on $16.72 billion expected, options pricing a 14% swing — alongside Amgen, at about $5.91 on $10.27 billion, Arista Networks, and Booking Holdings. Every one of them will be graded the same way Apple was: not on the quarter they finished, but on the one they promise next.

The invention spotlight

One genuinely new thing, and it's a medicine. On Monday, the FDA gave tentative approval to the first generic version of lenacapavir — the twice-yearly injection that prevents HIV — developed by India's Dr. Reddy's Laboratories, just 16 months after Gilead's original product was approved in June 2025. In trials, the shot was more than 99.9% effective at preventing HIV, which makes it one of the most powerful prevention tools ever built — two injections a year instead of a pill every day. The human story is the price and the paperwork. Under a voluntary license from Gilead, the generic will cost $40 per person per year across 120 low- and middle-income countries — the same price as the daily pills it replaces, for a product people actually have to remember twice a year. Tentative approval is the FDA's label for a generic held back by the originator's patent — it can't be sold in the U.S. yet, but it unlocks U.S. government procurement and speeds approval elsewhere. First supplies are expected before the end of this year, broader availability in 2027, with Zambia expected to be the first country to receive shipments. Sixteen months from breakthrough to a $40 generic aimed at the countries with the most cases. That almost never happens this fast.

The oversold corner

The screen re-ran this morning on 127 assets — large caps, midcaps, microcaps, and the top cryptos, from Yahoo Finance and CoinGecko daily closes — and 27 meet all three tests: RSI at or below 35, MACD bearish, and price below the 90-day average. The top five barely changed names, but every one of them sank deeper on Monday, which tells you the selling isn't done. Alphabet at $278.99, RSI 21.2, 18.7% below its 90-day average — still the most oversold big name on the board, still carrying last Thursday's earnings wipeout. Intel at $59.97, RSI 23.0, 41.0% below its average — Friday's historic drop, followed by another 8.8% on Monday. Fortinet at $126.21, RSI 23.6, 23.6% below, still sliding after its earnings dive. Cipher Mining at $6.86, RSI 24.1, 59.2% below its average — the Bitcoin miners remain pinned under the Bitcoin price and the Binance headlines at the same time. And D-Wave Quantum (QBTS) at $10.09, RSI 24.7, 41.6% below — no single headline there, just the speculative end of the tech trade getting sold with everything else that has a story and no earnings. The most oversold coin is Solana at $92.79, RSI 29.0, 8.4% below its 90-day average. Oversold is a description, not a buy idea.

The BogusAPY angle

Two hooks. First, read Oracle's bond coupons as a yield reality check. A giant company with real revenue is paying 7% to 8.65% to borrow long-term money for the AI buildout — and selling its own stock at an 11% discount to raise the rest. That is what money actually costs right now when the borrower is real and the bill is due. So when a platform advertises a smooth 20% APY, the script writes itself: Oracle pays 8.65% and takes a stock-price beating for the privilege — where exactly is the extra eleven points coming from on the platform's side of the trade? Second, the quiet migration: OKX just published its 49th straight proof-of-reserves report, and its customers' Bitcoin balances jumped 9.66% in a month, to 156,609 Bitcoin — the same month Binance lost $6.3 billion. Users are voting with their coins for the exchange that shows its work monthly. Where your coins sit while they "earn" is part of the yield question, and tomorrow's Binance snapshot is the next exhibit either way.

Get posts like this by email: Subscribe to BogusAPY

Follow BogusAPY on X: @BogusAPY

Sources: Reuters via multiple carriers (Nov 2 closes: Dow 51,983.98 +0.41%, S&P 500 7,541.40 −0.51%, Nasdaq 25,164.32 −1.07%, Nasdaq-100 27,989.82 −1.39% and >10% below its record close, confirming a correction; technology −2.66%, Intel −8.8%, Marvell −12.72%, Oracle −8.85%; oil: WTI settled $96.46 −7.36% and Brent $104.77 −7.63% Monday, then WTI $98.06 +1.66% and Brent $106.61 +1.76% at 0744 GMT Tuesday after the U.S. strike on Iran's Qeshm Island and an Iranian official saying a deal was far off; Apple −4.5% premarket on margin guidance; midterms: BetInt-aggregated prediction prices implying Democrats 95% for the House and 76% for the Senate, $1.48B+ wagered, Kalshi $1.33B volume; S&P 500 options pricing ~0.8% Wednesday move per ORATS), Apple fiscal Q4 2026 release and call coverage (revenue $114.48B vs $113.39B consensus, EPS $2.10 vs $1.99, iPhone $57.58B, Services $31.57B, December-quarter gross-margin guidance 45–46% vs 46.3% expected on memory costs), Palantir Q3 2026 release via CNBC/LSEG and Fool transcript (revenue $2.313B vs $2.18B, adjusted EPS $0.44 vs $0.41, U.S. commercial revenue $984M +148% passing U.S. government $953M for the first time, full-year guide raised to $8.53B; U.S. commercial contract value +11% per William Blair), Oracle via Reuters (Nov 2: $20B raise — 86.2M shares priced at $116, an 11.2% discount, plus bonds at 7%–8.65% coupons maturing 2029–2046; stock −8.8% to $119.22, ~−39% YTD; $125.34B borrowings at Aug 31 vs $67.36B fiscal 2026 revenue; the $20B matches the through-fiscal-2030 ceiling set at the Oct 28 investor day), Pfizer Q3 2026 release via Business Wire and Reuters/LSEG (adjusted EPS $0.87 vs $0.73, revenue $16.6B vs ~$15.87B, full-year guidance raised to $62–64B revenue and $2.95–3.05 adjusted EPS), Shopify Q3 2026 release and Barron's/Investor's Business Daily (adjusted EPS $0.49 vs $0.47, revenue $3.742B, GMV $119.1B vs ~$120.96B expected; shares ~−19% premarket, on pace for worst day on record per Dow Jones Market Data), Hyper Stocks and TipRanks earnings calendars (Nov 3 after close: AMD ~$1.97 / ~$13.22B, Super Micro ~$1.26 / ~$16.72B, Amgen ~$5.91 / ~$10.27B, Arista ~$1.10 / ~$3.40B, Booking Holdings; implied moves AMD ±9.11%, SMCI ±13.99%), CoinGecko via CoinGabbar (BTC $77,178.96 −2.0%, ETH $2,259.53 −1.5% at Nov 3 01:30 UTC; global market cap $2.67T) and FXStreet (crypto market −2% to $2.57T, six-week low; BTC ~$76.6K), Alternative.me via KuCoin, CoinGabbar and FXStreet (Fear & Greed 26, Fear — down from 37 yesterday, 48 last week, 65 last month), Binance Security Incident Recovery Update #6 via Cointelegraph and MABOnChain (second withdrawal phase opening Nov 3 from 04:00 UTC; DefiLlama net outflows $2.57B Monday vs $6.1B Sunday; ~95% of stolen funds replaced per Binance; fresh reserve snapshot due Nov 4), Bitcoin.com News (OKX 49th proof of reserves: customer BTC 156,609, +9.66% month over month), Clinton Health Access Initiative release Nov 2 and QNC News (FDA tentative approval of Dr. Reddy's generic injectable lenacapavir, first generic, $40 per person per year for 120 low- and middle-income countries, >99.9% effective in trials, first supplies expected by end of 2026), Yahoo Finance and CoinGecko (oversold screener, 127 assets, 27 flagged). Not financial advice.